| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 101 | 2023 | 11059 | 6.710 |
Why?
|
| Urology | 27 | 2023 | 396 | 6.440 |
Why?
|
| Cystectomy | 40 | 2022 | 686 | 5.700 |
Why?
|
| Medicare | 77 | 2023 | 6565 | 5.340 |
Why?
|
| Urinary Bladder Neoplasms | 50 | 2022 | 2248 | 5.330 |
Why?
|
| Prostatectomy | 49 | 2023 | 1879 | 5.070 |
Why?
|
| Surgicenters | 11 | 2016 | 46 | 4.240 |
Why?
|
| Ambulatory Surgical Procedures | 15 | 2017 | 455 | 3.960 |
Why?
|
| Radiotherapy, Intensity-Modulated | 12 | 2017 | 806 | 2.700 |
Why?
|
| Urologic Surgical Procedures | 17 | 2017 | 301 | 2.690 |
Why?
|
| Nephrectomy | 21 | 2022 | 1048 | 2.660 |
Why?
|
| Urinary Calculi | 9 | 2014 | 91 | 2.470 |
Why?
|
| Quality of Health Care | 27 | 2019 | 4370 | 2.040 |
Why?
|
| Robotics | 14 | 2013 | 899 | 1.920 |
Why?
|
| SEER Program | 30 | 2020 | 1507 | 1.900 |
Why?
|
| Cost Savings | 10 | 2020 | 925 | 1.880 |
Why?
|
| Surgery Department, Hospital | 6 | 2014 | 175 | 1.830 |
Why?
|
| United States | 132 | 2023 | 69859 | 1.690 |
Why?
|
| Laparoscopy | 20 | 2012 | 2148 | 1.630 |
Why?
|
| Aged | 187 | 2023 | 163178 | 1.570 |
Why?
|
| Patient Readmission | 16 | 2020 | 3117 | 1.480 |
Why?
|
| Diffusion of Innovation | 8 | 2014 | 725 | 1.410 |
Why?
|
| Kidney Neoplasms | 20 | 2022 | 4260 | 1.390 |
Why?
|
| Health Care Costs | 19 | 2020 | 3207 | 1.380 |
Why?
|
| Male | 245 | 2023 | 349776 | 1.290 |
Why?
|
| Ureteroscopy | 8 | 2011 | 143 | 1.260 |
Why?
|
| Prostate | 15 | 2023 | 1763 | 1.250 |
Why?
|
| Reimbursement Mechanisms | 7 | 2021 | 670 | 1.220 |
Why?
|
| Urinary Incontinence | 5 | 2017 | 496 | 1.210 |
Why?
|
| Androstenes | 7 | 2022 | 168 | 1.160 |
Why?
|
| Phenylthiohydantoin | 7 | 2022 | 193 | 1.150 |
Why?
|
| Ownership | 6 | 2023 | 332 | 1.140 |
Why?
|
| Kidney Calculi | 9 | 2018 | 465 | 1.130 |
Why?
|
| Prospective Payment System | 2 | 2022 | 133 | 1.110 |
Why?
|
| Prostate-Specific Antigen | 20 | 2023 | 2471 | 1.100 |
Why?
|
| Surgical Procedures, Operative | 7 | 2020 | 1877 | 1.090 |
Why?
|
| Cost of Illness | 5 | 2014 | 1859 | 1.070 |
Why?
|
| Cystoscopy | 4 | 2015 | 133 | 1.040 |
Why?
|
| Humans | 305 | 2023 | 743811 | 1.040 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2019 | 397 | 1.000 |
Why?
|
| Retrospective Studies | 81 | 2023 | 77410 | 1.000 |
Why?
|
| Length of Stay | 19 | 2020 | 6311 | 0.980 |
Why?
|
| Suburethral Slings | 3 | 2013 | 76 | 0.940 |
Why?
|
| Aged, 80 and over | 67 | 2021 | 57744 | 0.930 |
Why?
|
| Health Expenditures | 7 | 2020 | 2348 | 0.930 |
Why?
|
| Carcinoma, Renal Cell | 12 | 2022 | 3142 | 0.910 |
Why?
|
| Certificate of Need | 2 | 2012 | 12 | 0.890 |
Why?
|
| Reimbursement, Incentive | 6 | 2023 | 540 | 0.880 |
Why?
|
| Urinary Bladder, Overactive | 2 | 2015 | 106 | 0.860 |
Why?
|
| Physician Self-Referral | 2 | 2014 | 18 | 0.860 |
Why?
|
| Watchful Waiting | 5 | 2021 | 491 | 0.850 |
Why?
|
| Florida | 13 | 2019 | 435 | 0.850 |
Why?
|
| Physicians | 9 | 2023 | 4569 | 0.850 |
Why?
|
| Erectile Dysfunction | 6 | 2017 | 436 | 0.820 |
Why?
|
| Urinary Incontinence, Stress | 3 | 2013 | 183 | 0.820 |
Why?
|
| Regional Medical Programs | 2 | 2015 | 71 | 0.780 |
Why?
|
| Unnecessary Procedures | 7 | 2018 | 432 | 0.760 |
Why?
|
| Ureteral Calculi | 5 | 2003 | 109 | 0.760 |
Why?
|
| Urinary Retention | 4 | 2015 | 111 | 0.760 |
Why?
|
| Nitriles | 8 | 2022 | 953 | 0.750 |
Why?
|
| Neoplasm Staging | 24 | 2018 | 11036 | 0.750 |
Why?
|
| Adrenergic alpha-Antagonists | 3 | 2013 | 174 | 0.730 |
Why?
|
| Urinary Bladder | 5 | 2022 | 1173 | 0.710 |
Why?
|
| Economics, Hospital | 2 | 2019 | 213 | 0.700 |
Why?
|
| Hospitals | 12 | 2023 | 3953 | 0.700 |
Why?
|
| Aortic Valve Stenosis | 3 | 2021 | 1955 | 0.700 |
Why?
|
| Benzamides | 7 | 2022 | 1383 | 0.690 |
Why?
|
| Health Services Misuse | 3 | 2012 | 243 | 0.680 |
Why?
|
| Brachytherapy | 3 | 2023 | 1247 | 0.670 |
Why?
|
| Episode of Care | 1 | 2019 | 126 | 0.670 |
Why?
|
| Nephrostomy, Percutaneous | 3 | 2015 | 85 | 0.650 |
Why?
|
| Middle Aged | 123 | 2022 | 213241 | 0.650 |
Why?
|
| Electric Stimulation Therapy | 2 | 2015 | 605 | 0.630 |
Why?
|
| Biomedical Technology | 1 | 2020 | 220 | 0.630 |
Why?
|
| Ambulatory Care Facilities | 2 | 2017 | 934 | 0.620 |
Why?
|
| Health Care Reform | 5 | 2016 | 1261 | 0.610 |
Why?
|
| Quality Indicators, Health Care | 8 | 2015 | 1831 | 0.610 |
Why?
|
| Vertebroplasty | 1 | 2018 | 77 | 0.610 |
Why?
|
| Urologic Neoplasms | 3 | 2010 | 318 | 0.610 |
Why?
|
| Lymph Node Excision | 5 | 2013 | 1262 | 0.600 |
Why?
|
| Fee-for-Service Plans | 3 | 2021 | 694 | 0.600 |
Why?
|
| Delivery of Health Care | 11 | 2023 | 5319 | 0.600 |
Why?
|
| Female | 128 | 2022 | 380020 | 0.590 |
Why?
|
| Calcium Channel Blockers | 3 | 2013 | 692 | 0.590 |
Why?
|
| Logistic Models | 24 | 2023 | 13404 | 0.580 |
Why?
|
| Postoperative Complications | 27 | 2020 | 15281 | 0.570 |
Why?
|
| Patient Discharge | 9 | 2019 | 3317 | 0.570 |
Why?
|
| Ureter | 6 | 2017 | 375 | 0.550 |
Why?
|
| Renal Colic | 2 | 2013 | 31 | 0.550 |
Why?
|
| Practice Management, Medical | 1 | 2017 | 196 | 0.530 |
Why?
|
| Cohort Studies | 29 | 2023 | 40545 | 0.520 |
Why?
|
| Drug Industry | 2 | 2021 | 746 | 0.520 |
Why?
|
| Kidney Pelvis | 4 | 2017 | 188 | 0.510 |
Why?
|
| Prostheses and Implants | 2 | 2013 | 1385 | 0.510 |
Why?
|
| Insurance Claim Review | 2 | 2017 | 719 | 0.500 |
Why?
|
| Endoscopy | 4 | 2013 | 1781 | 0.500 |
Why?
|
| Recovery of Function | 7 | 2016 | 2922 | 0.490 |
Why?
|
| Guideline Adherence | 5 | 2019 | 2265 | 0.490 |
Why?
|
| Quality Assurance, Health Care | 4 | 2013 | 2211 | 0.490 |
Why?
|
| Office Visits | 1 | 2019 | 598 | 0.490 |
Why?
|
| Electrocoagulation | 1 | 2015 | 158 | 0.490 |
Why?
|
| Hospital Administration | 2 | 2008 | 353 | 0.480 |
Why?
|
| Fees and Charges | 2 | 2014 | 195 | 0.480 |
Why?
|
| Ureteral Obstruction | 4 | 2017 | 296 | 0.470 |
Why?
|
| Patient Care Management | 1 | 2017 | 306 | 0.470 |
Why?
|
| Mitomycin | 1 | 2014 | 259 | 0.470 |
Why?
|
| Treatment Outcome | 51 | 2023 | 63042 | 0.460 |
Why?
|
| Medicare Part B | 1 | 2014 | 108 | 0.460 |
Why?
|
| Diagnostic Imaging | 4 | 2014 | 3503 | 0.460 |
Why?
|
| Electrodes, Implanted | 2 | 2015 | 825 | 0.450 |
Why?
|
| Technology Transfer | 1 | 2013 | 44 | 0.450 |
Why?
|
| Healthcare Disparities | 4 | 2015 | 3155 | 0.450 |
Why?
|
| Colectomy | 5 | 2021 | 680 | 0.440 |
Why?
|
| Quality of Life | 18 | 2022 | 12788 | 0.430 |
Why?
|
| Convalescence | 2 | 2016 | 105 | 0.430 |
Why?
|
| Health Care Sector | 1 | 2014 | 194 | 0.430 |
Why?
|
| Medicare Part D | 4 | 2021 | 328 | 0.430 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2019 | 941 | 0.420 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2019 | 1537 | 0.420 |
Why?
|
| Urolithiasis | 2 | 2013 | 132 | 0.410 |
Why?
|
| Aftercare | 4 | 2018 | 870 | 0.400 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2012 | 337 | 0.390 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 8035 | 0.390 |
Why?
|
| Histocytological Preparation Techniques | 2 | 2001 | 30 | 0.380 |
Why?
|
| Echocardiography, Stress | 1 | 2011 | 131 | 0.380 |
Why?
|
| Surgical Mesh | 1 | 2013 | 276 | 0.380 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 690 | 0.370 |
Why?
|
| Salvage Therapy | 4 | 2018 | 1275 | 0.370 |
Why?
|
| Risk Adjustment | 3 | 2019 | 594 | 0.370 |
Why?
|
| Administration, Intravesical | 4 | 2011 | 91 | 0.360 |
Why?
|
| Health Status | 5 | 2019 | 4031 | 0.360 |
Why?
|
| Lithotripsy | 3 | 2011 | 142 | 0.350 |
Why?
|
| Patient Admission | 4 | 2018 | 1380 | 0.340 |
Why?
|
| Colic | 1 | 2009 | 42 | 0.340 |
Why?
|
| Radiotherapy, Conformal | 1 | 2012 | 548 | 0.330 |
Why?
|
| Coronary Artery Bypass | 3 | 2021 | 2288 | 0.330 |
Why?
|
| Patient Satisfaction | 5 | 2021 | 3391 | 0.320 |
Why?
|
| Fee Schedules | 1 | 2008 | 86 | 0.320 |
Why?
|
| Health Resources | 1 | 2014 | 912 | 0.320 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2010 | 392 | 0.310 |
Why?
|
| Quality Improvement | 3 | 2019 | 3750 | 0.310 |
Why?
|
| Time Factors | 23 | 2019 | 40038 | 0.310 |
Why?
|
| Confidence Intervals | 6 | 2016 | 2971 | 0.310 |
Why?
|
| Prostatic Hyperplasia | 4 | 2013 | 518 | 0.310 |
Why?
|
| Socioeconomic Factors | 8 | 2018 | 7784 | 0.300 |
Why?
|
| Androgen Antagonists | 7 | 2023 | 1376 | 0.300 |
Why?
|
| Dementia | 1 | 2021 | 2518 | 0.300 |
Why?
|
| Hospital Mortality | 8 | 2017 | 5316 | 0.290 |
Why?
|
| Biostatistics | 2 | 2019 | 161 | 0.290 |
Why?
|
| Delayed Diagnosis | 1 | 2010 | 441 | 0.290 |
Why?
|
| Kidney Diseases | 2 | 2009 | 2146 | 0.290 |
Why?
|
| Survivors | 4 | 2014 | 2291 | 0.290 |
Why?
|
| Drug Prescriptions | 4 | 2021 | 1636 | 0.280 |
Why?
|
| Pneumonectomy | 2 | 2018 | 1098 | 0.280 |
Why?
|
| Insurance Benefits | 2 | 2018 | 183 | 0.280 |
Why?
|
| Internship and Residency | 3 | 2022 | 5787 | 0.280 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2022 | 9239 | 0.270 |
Why?
|
| Centralized Hospital Services | 1 | 2005 | 18 | 0.270 |
Why?
|
| Cataract Extraction | 1 | 2010 | 481 | 0.270 |
Why?
|
| Fear | 1 | 2014 | 1438 | 0.270 |
Why?
|
| Adult | 54 | 2019 | 213889 | 0.270 |
Why?
|
| Learning | 1 | 2015 | 1710 | 0.260 |
Why?
|
| Carcinoma in Situ | 1 | 2011 | 805 | 0.260 |
Why?
|
| Neoadjuvant Therapy | 5 | 2022 | 2727 | 0.260 |
Why?
|
| Motivation | 3 | 2023 | 1971 | 0.260 |
Why?
|
| Rhinitis | 1 | 2012 | 690 | 0.260 |
Why?
|
| Regional Health Planning | 1 | 2005 | 97 | 0.260 |
Why?
|
| Radiation Injuries | 1 | 2012 | 1180 | 0.250 |
Why?
|
| Databases, Factual | 12 | 2018 | 7729 | 0.250 |
Why?
|
| Orgasm | 1 | 2004 | 61 | 0.240 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2019 | 1458 | 0.240 |
Why?
|
| Intraoperative Care | 1 | 2008 | 767 | 0.240 |
Why?
|
| Hospital Costs | 3 | 2018 | 985 | 0.240 |
Why?
|
| Models, Theoretical | 5 | 2019 | 3587 | 0.240 |
Why?
|
| Neoplasm Invasiveness | 7 | 2020 | 3617 | 0.240 |
Why?
|
| Referral and Consultation | 6 | 2018 | 3530 | 0.240 |
Why?
|
| Odds Ratio | 11 | 2019 | 9848 | 0.240 |
Why?
|
| Testicular Neoplasms | 2 | 2007 | 803 | 0.230 |
Why?
|
| Pelvis | 1 | 2008 | 730 | 0.230 |
Why?
|
| Urethra | 1 | 2006 | 407 | 0.230 |
Why?
|
| Arthroscopy | 1 | 2010 | 926 | 0.230 |
Why?
|
| Esophagectomy | 1 | 2007 | 447 | 0.230 |
Why?
|
| Sinusitis | 1 | 2012 | 921 | 0.230 |
Why?
|
| Laser Therapy | 4 | 2013 | 1071 | 0.230 |
Why?
|
| Benchmarking | 2 | 2007 | 1042 | 0.230 |
Why?
|
| Age Factors | 11 | 2019 | 18355 | 0.230 |
Why?
|
| Group Practice | 2 | 2021 | 149 | 0.220 |
Why?
|
| Decision Making | 3 | 2019 | 3887 | 0.220 |
Why?
|
| Survival Rate | 11 | 2017 | 12786 | 0.210 |
Why?
|
| Colonoscopy | 1 | 2010 | 1367 | 0.210 |
Why?
|
| Cost-Benefit Analysis | 7 | 2019 | 5388 | 0.210 |
Why?
|
| Sex | 1 | 2002 | 57 | 0.210 |
Why?
|
| Survival Analysis | 8 | 2018 | 10251 | 0.210 |
Why?
|
| Transurethral Resection of Prostate | 2 | 2013 | 83 | 0.210 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2010 | 1017 | 0.210 |
Why?
|
| Emergency Service, Hospital | 4 | 2018 | 7658 | 0.210 |
Why?
|
| Abdomen | 1 | 2008 | 1117 | 0.210 |
Why?
|
| Penile Prosthesis | 1 | 2002 | 29 | 0.210 |
Why?
|
| Hysterectomy | 1 | 2008 | 927 | 0.210 |
Why?
|
| Medication Adherence | 3 | 2020 | 2063 | 0.200 |
Why?
|
| Seminal Vesicles | 2 | 2022 | 99 | 0.200 |
Why?
|
| Mass Screening | 3 | 2019 | 5251 | 0.200 |
Why?
|
| Regression Analysis | 5 | 2021 | 6457 | 0.200 |
Why?
|
| Health Services Research | 4 | 2015 | 1836 | 0.200 |
Why?
|
| Proportional Hazards Models | 9 | 2016 | 12354 | 0.200 |
Why?
|
| Hospital-Physician Joint Ventures | 1 | 2021 | 30 | 0.190 |
Why?
|
| Workload | 1 | 2007 | 849 | 0.190 |
Why?
|
| Utilization Review | 3 | 2007 | 392 | 0.190 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2004 | 355 | 0.190 |
Why?
|
| Hormones | 2 | 2023 | 889 | 0.190 |
Why?
|
| Health Policy | 3 | 2020 | 2662 | 0.190 |
Why?
|
| Perioperative Care | 2 | 2014 | 1002 | 0.180 |
Why?
|
| Neuroendocrine Cells | 1 | 2021 | 61 | 0.180 |
Why?
|
| Lithotripsy, Laser | 1 | 2000 | 45 | 0.180 |
Why?
|
| Risk | 5 | 2015 | 9677 | 0.180 |
Why?
|
| Health Care Surveys | 4 | 2019 | 2453 | 0.180 |
Why?
|
| Cell Transdifferentiation | 1 | 2021 | 172 | 0.180 |
Why?
|
| Prognosis | 16 | 2021 | 29052 | 0.180 |
Why?
|
| Costs and Cost Analysis | 3 | 2020 | 1680 | 0.180 |
Why?
|
| Algorithms | 5 | 2018 | 13869 | 0.180 |
Why?
|
| Urination Disorders | 2 | 2011 | 241 | 0.170 |
Why?
|
| Disease-Free Survival | 6 | 2023 | 6895 | 0.170 |
Why?
|
| Health Services Accessibility | 4 | 2011 | 5136 | 0.170 |
Why?
|
| Urinary Diversion | 3 | 2017 | 138 | 0.170 |
Why?
|
| Michigan | 4 | 2018 | 350 | 0.170 |
Why?
|
| Biomedical Research | 3 | 2019 | 3308 | 0.170 |
Why?
|
| Patient-Centered Care | 3 | 2021 | 1438 | 0.170 |
Why?
|
| Medical Oncology | 2 | 2017 | 2267 | 0.170 |
Why?
|
| Guidelines as Topic | 2 | 2018 | 1404 | 0.170 |
Why?
|
| Antineoplastic Agents | 7 | 2023 | 13691 | 0.170 |
Why?
|
| Mortality | 4 | 2018 | 2862 | 0.170 |
Why?
|
| Risk Assessment | 14 | 2018 | 23327 | 0.170 |
Why?
|
| Castration | 1 | 2018 | 158 | 0.170 |
Why?
|
| Adolescent | 16 | 2018 | 85729 | 0.160 |
Why?
|
| Pain, Postoperative | 2 | 2016 | 1642 | 0.160 |
Why?
|
| Policy | 1 | 2022 | 508 | 0.160 |
Why?
|
| Carcinoma | 2 | 2013 | 2375 | 0.160 |
Why?
|
| Orchiectomy | 2 | 2018 | 468 | 0.160 |
Why?
|
| Young Adult | 14 | 2018 | 56392 | 0.160 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2019 | 1462 | 0.150 |
Why?
|
| Neoplasms | 6 | 2021 | 21675 | 0.150 |
Why?
|
| Poisson Distribution | 2 | 2009 | 513 | 0.150 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 1429 | 0.150 |
Why?
|
| Lymph Nodes | 2 | 2013 | 3476 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2020 | 6539 | 0.150 |
Why?
|
| Registries | 7 | 2018 | 8090 | 0.150 |
Why?
|
| Primary Health Care | 2 | 2010 | 4556 | 0.150 |
Why?
|
| Organ Transplantation | 1 | 2007 | 1140 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3608 | 0.140 |
Why?
|
| Biopsy | 6 | 2016 | 6750 | 0.140 |
Why?
|
| Veterans | 2 | 2021 | 2519 | 0.140 |
Why?
|
| Diagnosis-Related Groups | 2 | 2010 | 455 | 0.140 |
Why?
|
| Prosthesis Failure | 1 | 2002 | 1203 | 0.140 |
Why?
|
| Sexual Behavior | 2 | 2015 | 2049 | 0.140 |
Why?
|
| Subacute Care | 1 | 2018 | 168 | 0.140 |
Why?
|
| Hospital Bed Capacity | 2 | 2008 | 215 | 0.140 |
Why?
|
| Sexual Partners | 2 | 2021 | 728 | 0.130 |
Why?
|
| Follow-Up Studies | 14 | 2018 | 39001 | 0.130 |
Why?
|
| Urologic Diseases | 1 | 2018 | 243 | 0.130 |
Why?
|
| Chi-Square Distribution | 3 | 2011 | 3503 | 0.130 |
Why?
|
| Multivariate Analysis | 8 | 2018 | 12243 | 0.130 |
Why?
|
| Lumbosacral Plexus | 1 | 2015 | 53 | 0.130 |
Why?
|
| Research Design | 4 | 2019 | 5983 | 0.130 |
Why?
|
| Physician's Role | 2 | 2016 | 942 | 0.130 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 402 | 0.130 |
Why?
|
| Depression | 1 | 2014 | 7760 | 0.130 |
Why?
|
| Program Evaluation | 2 | 2018 | 2483 | 0.130 |
Why?
|
| Diagnostic Techniques, Urological | 2 | 2014 | 28 | 0.130 |
Why?
|
| Medicine | 2 | 2013 | 945 | 0.120 |
Why?
|
| Nephrons | 2 | 2009 | 220 | 0.120 |
Why?
|
| Hospice Care | 1 | 2021 | 672 | 0.120 |
Why?
|
| Tissue Adhesives | 2 | 2006 | 179 | 0.120 |
Why?
|
| Androgens | 3 | 2023 | 1247 | 0.120 |
Why?
|
| Myocardial Revascularization | 1 | 2018 | 841 | 0.120 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2013 | 24 | 0.120 |
Why?
|
| Drug Utilization | 2 | 2010 | 1183 | 0.120 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 240 | 0.120 |
Why?
|
| Adenocarcinoma | 4 | 2018 | 6363 | 0.120 |
Why?
|
| Cross-Sectional Studies | 7 | 2022 | 25032 | 0.110 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2014 | 808 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 20121 | 0.110 |
Why?
|
| Ureteral Neoplasms | 1 | 2013 | 111 | 0.110 |
Why?
|
| Radiosurgery | 1 | 2022 | 1331 | 0.110 |
Why?
|
| Risk Factors | 14 | 2023 | 72252 | 0.110 |
Why?
|
| Stents | 2 | 2001 | 3280 | 0.110 |
Why?
|
| Geography | 2 | 2021 | 669 | 0.100 |
Why?
|
| Probability | 3 | 2008 | 2505 | 0.100 |
Why?
|
| Urethral Stricture | 1 | 2011 | 51 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2019 | 1187 | 0.100 |
Why?
|
| Prospective Studies | 10 | 2018 | 53250 | 0.100 |
Why?
|
| Urogenital Neoplasms | 1 | 2013 | 137 | 0.100 |
Why?
|
| Living Donors | 2 | 2008 | 621 | 0.100 |
Why?
|
| Urothelium | 1 | 2013 | 277 | 0.100 |
Why?
|
| Sacrum | 1 | 2013 | 288 | 0.100 |
Why?
|
| Urinary Bladder Diseases | 1 | 2011 | 166 | 0.100 |
Why?
|
| Efficiency, Organizational | 2 | 2021 | 695 | 0.100 |
Why?
|
| Life Expectancy | 2 | 2018 | 1184 | 0.100 |
Why?
|
| Analysis of Variance | 4 | 2017 | 6356 | 0.090 |
Why?
|
| Managed Care Programs | 2 | 2014 | 950 | 0.090 |
Why?
|
| Secondary Prevention | 2 | 2015 | 1529 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2023 | 3439 | 0.090 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 4848 | 0.090 |
Why?
|
| Vaccinia virus | 2 | 2010 | 349 | 0.090 |
Why?
|
| HLA-A2 Antigen | 1 | 2010 | 213 | 0.090 |
Why?
|
| Psychometrics | 2 | 2010 | 3000 | 0.090 |
Why?
|
| Clinical Competence | 2 | 2013 | 4687 | 0.090 |
Why?
|
| Insurance Coverage | 2 | 2020 | 1900 | 0.090 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2019 | 875 | 0.090 |
Why?
|
| State Government | 1 | 2012 | 372 | 0.090 |
Why?
|
| Terminal Care | 1 | 2021 | 1694 | 0.090 |
Why?
|
| Outpatients | 1 | 2017 | 1488 | 0.090 |
Why?
|
| Peripheral Nerves | 1 | 2013 | 466 | 0.080 |
Why?
|
| Medicaid | 4 | 2021 | 2736 | 0.080 |
Why?
|
| Incidence | 7 | 2021 | 20948 | 0.080 |
Why?
|
| Patient Participation | 1 | 2018 | 1457 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 2715 | 0.080 |
Why?
|
| Taxoids | 2 | 2023 | 666 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2014 | 1917 | 0.080 |
Why?
|
| Reoperation | 2 | 2012 | 4200 | 0.080 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 933 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2017 | 1577 | 0.080 |
Why?
|
| Preoperative Care | 2 | 2010 | 2251 | 0.080 |
Why?
|
| Suture Techniques | 3 | 2011 | 797 | 0.080 |
Why?
|
| Diagnostic Services | 1 | 2007 | 34 | 0.080 |
Why?
|
| Medical Record Linkage | 1 | 2009 | 284 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2011 | 775 | 0.080 |
Why?
|
| Health Facility Size | 1 | 2007 | 64 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2008 | 261 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 2150 | 0.070 |
Why?
|
| Combined Modality Therapy | 4 | 2019 | 8637 | 0.070 |
Why?
|
| Early Detection of Cancer | 2 | 2018 | 3089 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2013 | 782 | 0.070 |
Why?
|
| Focus Groups | 2 | 2010 | 1320 | 0.070 |
Why?
|
| Positron-Emission Tomography | 2 | 2013 | 6237 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2009 | 474 | 0.070 |
Why?
|
| Kidney Transplantation | 3 | 2007 | 4251 | 0.070 |
Why?
|
| Deductibles and Coinsurance | 1 | 2009 | 316 | 0.070 |
Why?
|
| Hospitals, Proprietary | 1 | 2006 | 39 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2529 | 0.070 |
Why?
|
| Blood Loss, Surgical | 1 | 2010 | 660 | 0.070 |
Why?
|
| Health Status Indicators | 2 | 2010 | 970 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 35409 | 0.070 |
Why?
|
| Qualitative Research | 2 | 2019 | 2682 | 0.070 |
Why?
|
| Patient Selection | 3 | 2017 | 4210 | 0.070 |
Why?
|
| Autoantigens | 1 | 2010 | 892 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3839 | 0.070 |
Why?
|
| Ileus | 1 | 2005 | 58 | 0.070 |
Why?
|
| Fractures, Bone | 1 | 2017 | 1946 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2009 | 574 | 0.070 |
Why?
|
| Colonic Neoplasms | 2 | 2007 | 2542 | 0.070 |
Why?
|
| Observation | 1 | 2007 | 312 | 0.070 |
Why?
|
| Laparoscopes | 1 | 2005 | 41 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2278 | 0.060 |
Why?
|
| Hospitalization | 5 | 2020 | 10259 | 0.060 |
Why?
|
| Organ Size | 1 | 2010 | 2241 | 0.060 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2005 | 85 | 0.060 |
Why?
|
| Transplants | 1 | 2007 | 209 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2015 | 2050 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2018 | 8316 | 0.060 |
Why?
|
| Superior Mesenteric Artery Syndrome | 1 | 2004 | 6 | 0.060 |
Why?
|
| Life Tables | 1 | 2004 | 363 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2009 | 2298 | 0.060 |
Why?
|
| Hospitals, Urban | 1 | 2006 | 499 | 0.060 |
Why?
|
| Personal Satisfaction | 2 | 2021 | 641 | 0.060 |
Why?
|
| Models, Economic | 2 | 2018 | 712 | 0.060 |
Why?
|
| Editorial Policies | 2 | 2019 | 451 | 0.060 |
Why?
|
| Hospitals, Rural | 1 | 2005 | 172 | 0.060 |
Why?
|
| Employment | 1 | 2010 | 1132 | 0.060 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2005 | 147 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 15067 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 1581 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2010 | 1485 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2014 | 2614 | 0.060 |
Why?
|
| Ketoconazole | 1 | 2023 | 95 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4467 | 0.050 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2008 | 638 | 0.050 |
Why?
|
| Skilled Nursing Facilities | 1 | 2006 | 372 | 0.050 |
Why?
|
| Operating Rooms | 1 | 2009 | 817 | 0.050 |
Why?
|
| Neuromuscular Diseases | 1 | 2005 | 247 | 0.050 |
Why?
|
| Specialties, Surgical | 1 | 2007 | 391 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 2428 | 0.050 |
Why?
|
| Fiber Optic Technology | 1 | 2003 | 290 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2018 | 2617 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2018 | 1770 | 0.050 |
Why?
|
| Coitus | 1 | 2002 | 132 | 0.050 |
Why?
|
| Hernia, Inguinal | 1 | 2004 | 209 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 1180 | 0.050 |
Why?
|
| Sepsis | 1 | 2015 | 2593 | 0.050 |
Why?
|
| Telemedicine | 1 | 2018 | 2874 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2534 | 0.050 |
Why?
|
| Intraoperative Complications | 3 | 2005 | 1195 | 0.050 |
Why?
|
| Health Services Needs and Demand | 1 | 2009 | 1411 | 0.050 |
Why?
|
| Testicular Diseases | 1 | 2000 | 71 | 0.050 |
Why?
|
| Cancer Vaccines | 1 | 2008 | 1023 | 0.050 |
Why?
|
| Histoplasmosis | 1 | 2000 | 66 | 0.050 |
Why?
|
| Morbidity | 1 | 2006 | 1768 | 0.050 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2010 | 1209 | 0.050 |
Why?
|
| Home Care Services | 1 | 2006 | 608 | 0.050 |
Why?
|
| Social Class | 1 | 2009 | 1997 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3255 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2011 | 1796 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2008 | 1271 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2008 | 1400 | 0.040 |
Why?
|
| Income | 2 | 2020 | 1913 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2008 | 2258 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2004 | 547 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 6773 | 0.040 |
Why?
|
| Safety | 1 | 2003 | 1184 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 14714 | 0.040 |
Why?
|
| General Surgery | 1 | 2010 | 1636 | 0.040 |
Why?
|
| Copying Processes | 1 | 2018 | 5 | 0.040 |
Why?
|
| Child | 4 | 2014 | 77637 | 0.040 |
Why?
|
| Acute Kidney Injury | 2 | 2013 | 1968 | 0.040 |
Why?
|
| Private Sector | 1 | 2021 | 393 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 9944 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 15526 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2012 | 9139 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 1854 | 0.040 |
Why?
|
| Infant | 2 | 2009 | 35122 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2004 | 1240 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2019 | 21733 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 2007 | 1585 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 11708 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2009 | 40964 | 0.040 |
Why?
|
| Hematoma | 1 | 2002 | 758 | 0.040 |
Why?
|
| Occupational Diseases | 1 | 2005 | 1466 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2013 | 3480 | 0.040 |
Why?
|
| Hospital Communication Systems | 1 | 2016 | 51 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2011 | 13028 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2000 | 694 | 0.030 |
Why?
|
| Failure to Thrive | 1 | 2016 | 137 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 7270 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2002 | 2103 | 0.030 |
Why?
|
| Oncology Service, Hospital | 1 | 2014 | 57 | 0.030 |
Why?
|
| Ischemia | 1 | 2004 | 1907 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2018 | 601 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2017 | 550 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2020 | 1841 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 10896 | 0.030 |
Why?
|
| Laparotomy | 1 | 2016 | 473 | 0.030 |
Why?
|
| Health Surveys | 1 | 2004 | 4036 | 0.030 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2013 | 66 | 0.030 |
Why?
|
| Research Personnel | 1 | 2019 | 573 | 0.030 |
Why?
|
| Propensity Score | 1 | 2020 | 1781 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 19894 | 0.030 |
Why?
|
| Drug Costs | 1 | 2020 | 1105 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 3965 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 1639 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2018 | 1459 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2020 | 3912 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10179 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11524 | 0.030 |
Why?
|
| Models, Biological | 1 | 2009 | 9582 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2019 | 2538 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2013 | 426 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 1146 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2013 | 538 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4749 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2012 | 288 | 0.030 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 592 | 0.020 |
Why?
|
| Patient Preference | 1 | 2018 | 889 | 0.020 |
Why?
|
| Dilatation | 1 | 2011 | 291 | 0.020 |
Why?
|
| Hematuria | 1 | 2011 | 235 | 0.020 |
Why?
|
| Carboplatin | 1 | 2013 | 801 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2014 | 763 | 0.020 |
Why?
|
| Radiography | 1 | 2001 | 7010 | 0.020 |
Why?
|
| Insurance, Health | 2 | 2013 | 2492 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2021 | 2707 | 0.020 |
Why?
|
| Intestines | 2 | 2011 | 1923 | 0.020 |
Why?
|
| Comorbidity | 2 | 2016 | 10380 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2009 | 25609 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 788 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 684 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2013 | 826 | 0.020 |
Why?
|
| Fever | 1 | 2016 | 1616 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2459 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2011 | 987 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2013 | 973 | 0.020 |
Why?
|
| Neutropenia | 1 | 2013 | 895 | 0.020 |
Why?
|
| Testosterone | 1 | 2018 | 2297 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2008 | 803 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2017 | 2107 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2010 | 975 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7150 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 13980 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 3336 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2014 | 1533 | 0.020 |
Why?
|
| Obesity | 2 | 2006 | 12744 | 0.020 |
Why?
|
| Pain | 1 | 2002 | 4987 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2016 | 3420 | 0.020 |
Why?
|
| Hypertension | 1 | 2006 | 8480 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8337 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2013 | 1705 | 0.020 |
Why?
|
| Immunization | 1 | 2010 | 1255 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2008 | 395 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 1178 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1799 | 0.020 |
Why?
|
| Bone Density | 1 | 2017 | 3460 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2008 | 1369 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 2085 | 0.010 |
Why?
|
| Decision Trees | 1 | 2005 | 506 | 0.010 |
Why?
|
| Scrotum | 1 | 2004 | 115 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3874 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 13112 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2008 | 2718 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2010 | 1828 | 0.010 |
Why?
|
| Critical Care | 1 | 2015 | 2647 | 0.010 |
Why?
|
| Hand Injuries | 1 | 2005 | 242 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2015 | 3679 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2010 | 3205 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2008 | 1821 | 0.010 |
Why?
|
| Infection Control | 1 | 2008 | 964 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5179 | 0.010 |
Why?
|
| Short Bowel Syndrome | 1 | 2004 | 345 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2008 | 3547 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 2924 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2010 | 5973 | 0.010 |
Why?
|
| Necrosis | 1 | 2004 | 1642 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2720 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 2008 | 1539 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 6620 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2004 | 819 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9731 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15211 | 0.010 |
Why?
|
| Swine | 1 | 2006 | 5909 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2010 | 4437 | 0.010 |
Why?
|
| Mice | 2 | 2010 | 81154 | 0.010 |
Why?
|
| Animals | 3 | 2010 | 168660 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 16674 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 21824 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 7172 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 12718 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 18027 | 0.000 |
Why?
|